Provided by Tiger Fintech (Singapore) Pte. Ltd.

Avidity Biosciences, Inc.

28.90
+2.248.40%
Volume:856.29K
Turnover:24.30M
Market Cap:3.47B
PE:-10.01
High:29.36
Open:26.26
Low:26.01
Close:26.66
Loading ...
Mar 25, 2025

Major Issues Report

Form 8-K - Current report
Mar 17, 2025

Major Issues Report

Form 8-K - Current report
Mar 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 08, 2025

Major Issues Report

Form 8-K - Current report
Dec 16, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Dec 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 13, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Nov 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Nov 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 08, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities